Researchers

NISHIDA Naoshi

NISHIDA Naoshi: Clinical Professor

Faculty	Department of Medicine / Graduate School of Medical Sciences
Researchmap	https://researchmap.jp/naoshinishida

Education and Career

Education

- 1985 , Osaka Medical College, Faculty of Medicine,
- 1993 , Kyoto University, Graduate School of Medicine,

Academic & Professional Experience

Apr. 2021 - Today , Kindai University Faculty of Medicine Professor
Aug. 2011 - Mar. 2021 , Fuculty of Medicine Kindai University Department of Gastroenterology and Hepatology Associate Professor
Aug. 2006 - Jul. 2011 , Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology Assistant Professor/Lecture
Feb. 2004 - Jul. 2006 , Baylor University Medical Center Division of Gastroenterology Reserach Associate
Apr. 1997 - Jan. 2004 , Kyoto University Graduate School of Medicine Department of Medicine and Clinical Science Assistant Professor
May. 1996 - Apr. 1997 , Research Institute for Production Development Researcher

Research Activities

Research Areas

Informatics, Biological, health, and medical informatics
Life sciences, Genomics
Life sciences, Gastroenterology

Research Interests

data base, artificial Intelligence, Molecular Biology, Hepatology, Gastroenterology, Epigenetics, chromosome, tumor suppressor gene, Hepatocellular carcinoma

Published Papers

Correspondence to editorial on "Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway.".
Tomoko Aoki; Naoshi Nishida; Masatoshi Kudo
Clinical and molecular hepatology 28, Apr. 2025 , Refereed
Biomarkers and Management of Cholangiocarcinoma: Unveiling New Horizons for Precision Therapy
Naoshi Nishida
Cancers 17 (7) , 1243-1243, 6, Apr. 2025 , Refereed
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.
Bernardo Stefanini; Claudia Angela Maria Fulgenzi; Bernhard Scheiner; James Korolewicz; Jaekyung Cheon; Naoshi Nishida; Celina Ang; Thomas U Marron; Y Linda Wu; Anwaar Saeed; Brooke Wietharn; Lorenza Rimassa; Angelo Pirozzi; Antonella Cammarota; Tiziana Pressiani; Matthias Pinter; Lorenz Balcar; Yi-Hsiang Huang; Aman Mehan; Samuel Phen; Caterina Vivaldi; Francesca Salani; Gianluca Masi; Dominik Bettinger; Arndt Vogel; Martin Schönlein; Johann von Felden; Kornelius Schulze; Henning Wege; Adel Samson; Peter R Galle; Masatoshi Kudo; Giulia Francesca Manfredi; Ciro Celsa; Nichola Awosika; Alessio Cortellini; Amit G Singal; Rohini Sharma; Hong Jae Chon; Francesco Tovoli; Fabio Piscaglia; David James Pinato; Antonio D'Alessio
Journal of hepatocellular carcinoma 12 , 671-683, 4, Apr. 2025 , Refereed

Immunotherapy in Hepatocellular Carcinoma , Naoshi Nishida; Masatoshi Kudo , MDPI Books , Apr. 2023
Treatment of HCC using Atezolizumab＋Bevacizumab , Naoshi Nishida , TME and immune checkpoint inhibitors , TME and immune checkpoint inhibitors , アークメディア , Sep. 2021
AI diagnosis for Ultrasonography , Naoshi Nishida , Chapter 9 今後の課題と展望 , Chapter 9 今後の課題と展望 , オーム社 , Sep. 2021

Long-term survival outcomes in patients receiving atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma: an update of the AB-real study. , Bernardo Stefanini; Leonardo Brunetti; Pasquale Lombardi; Bernhard Scheiner; Matthias Pinter; Hong Jae Cho; Linda Wu; Celina Ang; Anwaar Saeed; Lorenza Rimassa; Giulia Tesini; Masatoshi Kudo; Naoshi Nishida; Pei-Chang Lee; Yi-Hsiang Huang; Wei-Fan Hsu; Gianluca Masi; Arndt Vogel; Amit Singal; Martin Schoenlei; Johann von Felde; Peter R. Galle; Giulia Francesca Manfredi; Neehar D. Parikh; Alessandro Parisi; Natascha Röhle; Yehia Abugabal; Ahmed Kaseb; Andrea Dalbeni; Brooke Wietha; Ciro Celsa; Giuseppe Cabibbo; Changhoon Yoo; Francesco Tovoli; Antonio D'alessio; Fabio Piscaglia; David J. Pinato , The European Association for the Study of Liver Disease (EASL) 2025 , 7, May. 2025
Development and Performance of AI in Supporting the Diagnosis of Liver Tumors Using BMode Ultrasound , Naoshi Nishida; Masatoshi Kudo , The European Association for the Study of Liver Disease (EASL) 2025 , 10, May. 2025
Role of Child-Turcotte-Pugh and ALBI scores in patients with non-cirrhotic hepatocellular carcinoma , Abelina Kreuter; Leonardo Brunetti; Lorenz Balcar; Claudia Fulgenzi; Tobias Meischl; Antonio D'alessio; Katharina Pomej; Jaekyung Cheon; Naoshi Nishida; Pei-Chang Lee; Linda Wu; Celina Ang; Anja Krall; Anwaar Saeed; Bernardo Stefanini; Antonella Cammarota; Tiziana Pressiani; Yehia Abugabal; Shadi Chamseddine; Brooke Wietha; Alessandro Parisi; Yi-Hsiang Huang; Samuel Phe; Caterina Vivaldi; Francesca Salani; Gianluca Masi; Natascha Röhle; Arndt Vogel; Johann von Felden; Kornelius Schulze; Marianna Sille; Michael Trauner; Adel Samson; Henning Wege; Fabio Piscaglia; Peter R. Galle; Rudolf Stauber; Masatoshi Kudo; Amit Singal; Haripriya Andanamala; Susanna V. Ulahann; Neehar D. Parikh; Alessio Cortellini; Ahmed Kaseb; Lorenza Rimassa; Hong Jae Cho; Ciro Celsa; Ashwini Arvi; Michael Li; Giulia Manfredi; Giuseppe Cabibbo; Katie Kelley; Paul El To; Bernhard Scheiner; David J. Pinato; Matthias Pinter , The European Association for the Study of Liver Disease (EASL) 2025 , 7, May. 2025

AI開発用超音波画像ビッグデータベースとオンライン性能評価試験システムの構築 , 西田直生志; 工藤正俊 , 肝臓 , 65 , Suppl.2 , A560 , A560 , Sep. 2024
肝疾患のゲノム・エピゲノム研究の近未来 bulk RNA-seqを利用したHCCの免疫細胞比率と予後比較 , 青木智子; 西田直生志; 工藤正俊 , 肝臓 , 65 , Suppl.2 , A611 , A611 , Sep. 2024
【今推しの肝胆膵研究手法と疾患モデル】新規モデルによる肝胆膵研究 AIを用いた肝画像診断の最前線 , 西田直生志 , 肝胆膵 , 89 , 2 , 229 , 236 , Aug. 2024

May. 2025, AME Publishing Company, Outstanding Authors
Jun. 2022, The Japan Society of Hepatology, Hepatology Research Citation Award
Apr. 2021, SRF, Research Grant

日本学術振興会, 科学研究費助成事業, 胆道癌のドライバー変異に着目した腫瘍免疫微小環境の再構築と治療最適化 , 近畿大学
日本学術振興会, 科学研究費助成事業, 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析 , 近畿大学
Smoking Research Foundation, 一般研究, Analysis of immunological microenvironment of tumor and effect of smoking habits for the development of personalized medicine in liver cancer , Kindai University